Track topics on Twitter Track topics that are important to you
Aerie Pharmaceuticals and DSM have entered into a collaborative research, development and license agreement, according to an Aerie press release.The agreement includes an option to license DSM’s bioerodible polymer implant technology in order to deliver Aerie’s compounds to treat retinal diseases, the release said.
Original Article: Aerie, DSM enter collaboration agreementNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...